This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Merck Sharp + Dohme Corp., Schering Corporation. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: Naoko Arai: Innovator in Nucleic Acid Technologies
Introduction
Naoko Arai is a prominent inventor based in Palo Alto, CA. She has made significant contributions to the field of molecular biology, particularly in the development of nucleic acid technologies. With a total of 2 patents, her work has implications for both diagnostic and therapeutic applications.
Latest Patents
Naoko Arai's latest patents include innovations related to nucleic acids encoding TNFγ and TNFx proteins. These patents describe nucleic acids encoding mammalian genes, including those from primates and rodents. They also cover purified proteins and their fragments, as well as antibodies, both polyclonal and monoclonal. The methods outlined in these patents provide valuable compositions for diagnostic and therapeutic utilities.
Career Highlights
Throughout her career, Naoko Arai has worked with notable companies such as Schering Corporation and Merck Sharp & Dohme Corp. Her experience in these organizations has allowed her to advance her research and contribute to significant scientific advancements.
Collaborations
Naoko has collaborated with esteemed colleagues, including Christi L. Parham and Daniel M. Gorman. These partnerships have fostered innovation and have been instrumental in her research endeavors.
Conclusion
Naoko Arai's contributions to nucleic acid technologies highlight her role as a leading inventor in the field. Her patents and collaborations reflect her commitment to advancing scientific knowledge and improving therapeutic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile